Medical ultrasound transducers require acoustic impedance matching layers to bridge the gap between piezoelectric ceramics (~30–38 MRayl) and biological tissue (~1.5–1.7 MRayl). Existing solutions—such as alumina–epoxy, anodic aluminum oxide–epoxy 1–3 composites, magnesium alloys, and gradient nanocomposites—rely on high-temperature curing, precision machining, or multi-step fabrication, which increase production costs and limit design flexibility. Viscoelastic suspensions offer a potential low-cost alternative, but prior to any clinical assessment, manufacturing protocols must be bounded at the exploratory stage. This study does not demonstrate impedance matching, quarter-wavelength performance, or immediate clinical relevance. This work defines a Stage 1 pre-pilot (Technology Readiness Level 2–3) exploratory study to bound manufacturing protocols, rank formulations, and identify candidate parameters for future Quality by Design implementation. Six formulations were tested in open-cell polyurethane foam matrix: thick cornstarch–water (50:50 wt%), thin cornstarch–water (66:33 wt%), polystyrene sulfonate (50:50 wt%), polyethylene glycol–fumed silica (40:60 wt%), boric acid–simethicone, and a boric acid–cornstarch hybrid. The 5 mm prototypes function as bulk composite samples rather than functional matching layers, and all testing was performed at audio frequencies (50 Hz–20 kHz) with uncalibrated consumer-grade instrumentation. At 50–1000 Hz, boric acid–simethicone exhibited the lowest attenuation (32 dB). At 10,000–20,000 Hz, polystyrene sulfonate and thin cornstarch showed the lowest attenuation (97 dB at 20 kHz). Attenuation increased with frequency; a dip between 100 and 1000 Hz was attributed to fixture interference. Two independent recordings were obtained per condition (n = 2). No inferential statistics, confidence intervals, or variance estimates were computed. The results establish a descriptive baseline but do not demonstrate impedance matching or immediate clinical relevance; the 5 mm prototypes function as bulk composite samples rather than quarter-wavelength matching layers. Should subsequent high-frequency validation prove promising, future work includes factorial or definitive screening designs, hydrophone calibration per international standards, Z = ρc measurements, substrate deconvolution, 0.5–1.0 mm layers for 650 kHz, phantom validation, and ISO 10993 biocompatibility screening.